The MSI-H HCC cases [146] exhibited a high tumor mutation burden (TMB), CD8+ lymphocyte infiltration, and low VEGF expression, consistent with immunogenic microenvironments, as seen in other MSI-H cancers (such as colorectal cancer [147]). This evidence concerns the gene CD8A and hepatocellular carcinoma.